SSG
KLRS

Summit Securities Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Summit Securities Group’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-873
Closed -$43K – 756
2023
Q3 		$43K Buy
+873
New +$43K ﹤0.01% 160